Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2015 –2029 | |
|
|
|
| USD 482.95 Billion | |
| % | |
|
Global Tissue Regeneration Market, By Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others), Raw Material (Synthetic, Genetically modified and Biological), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others), End-User (Hospital & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others) – Industry Trends and Forecast to 2029
Get Exclusive Sample Copy of this Report Here
Congenital illnesses, malformations, and disease-related tissue damage drive the demand for tissue regeneration. This factor is expected to shape the future trajectory of the global tissue regeneration market in the coming years. Tissue engineering is essentially a procedure for controlling, repairing, and improving the function of injured tissue. The tissue regeneration technique increases a patient's life expectancy by repairing diseased or damaged organs, such as the kidneys. Regenerative medicine has the potential to address the current organ donor shortage; for example, tissue-reengineered skin is extremely useful for foot and leg ulcers, burn wounds, and skin replacement.
Data Bridge Market Research analyses that the tissue regeneration market is expected to reach the value of USD 482.95 billion by the year 2029, at a CAGR of 25.44% during the forecast period. The growing demand for personalised medicines will aid in the expansion of the tissue regeneration market.
Tissue regeneration is the process of restoring or repairing damaged or diseased tissue by regrowing or replacing it. Congenital diseases, defects, and tissue damage caused by diseases promote the need for tissue regeneration. This technique includes a tissue engineering procedure that manages, restores, and improves the application of damaged tissue. The tissue regeneration procedure increases patients' life expectancy by restoring damaged organs, including the kidneys. Regenerative medicine has the potential to end the current shortage of organ donors; for example, tissue-reengineered skin is extremely beneficial for skin replacement, burn wounds, and ulcers that affect the leg and foot.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others), Raw Material (Synthetic, Genetically modified and Biological), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others), End-User (Hospital & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
Oppurtunities
|
Arteriocyte Medical Systems Inc. (U.S.), Athersys Inc. (U.S.), Cerapedics Inc. (U.S.), Co. Don AG (Germany), Cook Medical Inc. (U.S.), U.S. Stem Cell Inc. (U.S.), Cytori Therapeutics, Inc. (U.S.A), Cerapedicsm, Inc. (U.S.), Organogenesis, Inc. (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (U.S), ACell, Inc. (U.S.), Tissue Regenix (U.S.)
|
Drivers
The rising prevalence of chronic diseases, the use of biomarkers in disease diagnosis, the need for personalised medicines, and government grants and investments around the world are expected to drive the growth of the tissue regeneration market.
The increase in the use of 3d printing functions
The expansion of 3D printing functions in tissue regeneration, as a result of research and development and invention in biomaterials, nanotechnology, cell therapies, and drug delivery, is expected to amplify the growth of the tissue regeneration market during the forecast period.
Regulatory Compliance
Maintaining compliance with medical reforms and regulations raises the demand for these solutions.
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the tissue regeneration market.
.Restraints/Challenges
Strict government administrations, repayment concerns, particularly in emerging nations, and less funding in developing countries are the factors most likely to stymie the growth of the tissue regeneration market.
This tissue regeneration market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue regeneration market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The pandemic of COVID-19 has had a significant impact on the health-care industry. Since the COVID 19 pandemic, clinical tissue engineering research has been made unavailable, and non-COVID 19 clinical trials have been reduced. In the meantime, several pharmaceutical and biotech companies have shifted their focus to the development of COVID-19 treatment drugs and vaccines. Furthermore, a significant decrease in cell and tissue donation programmes has restrained the global tissue engineering market. As a result, clinical research delays and disruptions, as well as cancellations or delays in tissue replacement and reconstructive procedures, impede the global tissue engineering market's growth.
Recent Development
The tissue regeneration market is segmented on the basis technology, raw material, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
Based on the technology, the tissue regeneration market is segmented into cell therapy, stem cell therapy, stem cell sources, tissue vascularization, cell culturing and others.
Raw material
Based on the raw material, the tissue regeneration market is segmented into synthetic, genetically modified and biological.
Application
Based on the application, the tissue regeneration market is segmented into cardiovascular, oncology, dermatology, orthopaedic, neurology, ophthalmology and others.
End User
Based on the end-user, the tissue regeneration market is segmented into hospital and diagnostic centres, pharmaceutical and biotechnology companies, contract research organizations and others.
The tissue regeneration market is analysed and market size insights and trends are provided by country, technology, raw material, application and end-user as referenced above.
The countries covered in the tissue regeneration market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tissue regeneration market due to an ageing population and the availability of developed healthcare equipment. Factors such as an increase in the number of clinical trials to estimate product therapeutic potential, an increase in the incidence of chronic diseases, and an increase in public awareness of therapy's therapeutic potency are all driving the growth of the tissue regeneration market in the region. Europe is expected to see significant growth in the tissue regeneration market as a result of factors such as the easy availability of funds for R&D and the government's increasing support for the life science domain, which will further propel growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The tissue regeneration market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue regeneration market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue regeneration market. The data is available for historic period 2010-2020.
The tissue regeneration market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue regeneration market.
Some of the major players operating in the tissue regeneration market are
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.